Evidence map›Paper›PMID 32959201›Full record

ArticleNeurocritical care2020

Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care.

Alexis N Simpkins, Katharina M Busl, Edilberto Amorim, Carolina Barnett-Tapia, Mackenzie C Cervenka, Monica B Dhakar, Mark R Etherton, Celia Fung, Robert Griggs, Robert G Holloway and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Neurocritical care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 2 countries.

Alexis N SimpkinsDepartment of Neurology, McKnight Brain Institute, University of Florida College of Medicine, Room L3-100, 1149 Newell Drive, Gainesville, FL, 32611, USA. alexis.simpkins@neurology.ufl.edu.ORCID http://orcid.org/0000-0001-7529-4267
Katharina M BuslDepartment of Neurology, McKnight Brain Institute, University of Florida College of Medicine, Room L3-100, 1149 Newell Drive, Gainesville, FL, 32611, USA.
Edilberto AmorimDepartment of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Carolina Barnett-TapiaEllen and Martin Prosserman Centre for Neuromuscular Disorders, Toronto General Hospital, Toronto, ON, Canada.
Mackenzie C CervenkaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Monica B DhakarDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Mark R EthertonJ. Phillip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, USA.
Celia FungDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Robert GriggsDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Robert G HollowayDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Adam G KellyDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Imad R KhanDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Karlo J LizarragaDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Hannah G MadaganDepartment of Neurology, McKnight Brain Institute, University of Florida College of Medicine, Room L3-100, 1149 Newell Drive, Gainesville, FL, 32611, USA.
Chidinma L OnweniDepartment of Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA.
Humberto MestreCenter for Translational Neuromedicine, Department of Neurosurgery, University of Rochester Medical Center, Rochester, USA.
Alejandro A RabinsteinDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Clio RubinosDepartment of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Dawling A Dionisio-SantosDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Teddy S YounDepartment of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.
Lisa H MerckDepartment of Emergency Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
Carolina B MacielDepartment of Neurology, McKnight Brain Institute, University of Florida College of Medicine, Room L3-100, 1149 Newell Drive, Gainesville, FL, 32611, USA.
Neurotherapeutics Symposium 2019
University of Rochester Medical Center · USUniversity of Florida · USEmory University · USMayo Clinic · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USUniversity of Utah · USBoston University · USJohns Hopkins University · USToronto General Hospital · CABarrow Neurological Institute · USMassachusetts General Hospital · USWinnMed · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
EXPERIMENTAL THERAPEUTICS IN NEUROLOGICAL DISEASET32NS007338 · NINDS · UNIVERSITY OF ROCHESTER · PI ROBERT G. HOLLOWAY, Michael P McDermott · 1990 to 2026
$6.4M
Mechanisms of lung-dependent neutrophil priming in global cerebral ischemia-reperfusion injuryR01NS092455 · NINDS · UNIVERSITY OF ROCHESTER · PI HALTERMAN, MARC W · 2015 to 2025
$4.5M
Neurotherapeutics Symposium 2019 – accelerating the pace of translation in neurological emergencies by enhancing diverse workforce in neuroscience and promoting transdisciplinary team scienceR13NS111956 · NINDS · UNIVERSITY OF FLORIDA · PI GRIGGS, ROBERT C, MACIEL, CAROLINA B · 2019 to 2019
$20k
NCATS NIH HHS UL1 TR001863NINDS NIH HHS R01 NS092455NINDS NIH HHS R13 NS111956NINDS NIH HHS T32 NS007338
6 · The paper itself

Abstract

Effective treatment options for patients with life-threatening neurological disorders are limited. To address this unmet need, high-impact translational research is essential for the advancement and development of novel therapeutic approaches in neurocritical care. "The Neurotherapeutics Symposium 2019-Neurological Emergencies" conference, held in Rochester, New York, in June 2019, was designed to accelerate translation of neurocritical care research via transdisciplinary team science and diversity enhancement. Diversity excellence in the neuroscience workforce brings innovative and creative perspectives, and team science broadens the scientific approach by incorporating views from multiple stakeholders. Both are essential components needed to address complex scientific questions. Under represented minorities and women were involved in the organization of the conference and accounted for 30-40% of speakers, moderators, and attendees. Participants represented a diverse group of stakeholders committed to translational research. Topics discussed at the conference included acute ischemic and hemorrhagic strokes, neurogenic respiratory dysregulation, seizures and status epilepticus, brain telemetry, neuroprognostication, disorders of consciousness, and multimodal monitoring. In these proceedings, we summarize the topics covered at the conference and suggest the groundwork for future high-yield research in neurologic emergencies.

Indexed as

EmergenciesNervous System DiseasesFemaleHumansConference proceedingsDiversity excellenceNeurocritical careTeam scienceTranslational research

Identifiers

PMID32959201
PMCPMC7736003
OpenAlexW3087399911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.